Castle Rock Wealth Management, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
Ava Hoppe | 24 July, 2023
Castle Rock Wealth Management, LLC, a well-known investment firm, recently released its Q1 2023 and Q2 2023 13F holdings comparison. The 13F filings provide an insight into the changing investment portfolios of various funds. In this article, we will analyze the notable changes in Castle Rock Wealth Management, LLC's holdings during the first and second quarters of 2023.
GOLDMAN SACHS ETF TR (GBIL)
In the Q2 2023 holdings, Castle Rock Wealth Management, LLC reduced its shares of Goldman Sachs ETF TR (GBIL) by 17.9%. The value of these shares also decreased from $21,745,000 in Q1 2023 to $17,851,000 in Q2 2023.
ISHARES TR (SHV)
Castle Rock Wealth Management, LLC increased its shares of iShares TR (SHV) by 3.2% in Q2 2023, representing a positive growth in their investments. The value of these shares also rose from $15,362,000 in Q1 2023 to $15,848,000 in Q2 2023.
CHEVRON CORP NEW (CVX)
Castle Rock Wealth Management, LLC expanded its holdings of Chevron Corp New (CVX) by 4% in Q2 2023. The value of these shares increased from $14,790,000 in Q1 2023 to $15,377,000 in Q2 2023.
COCA COLA CO (KO)
In Q2 2023, Castle Rock Wealth Management, LLC kept its holdings of Coca Cola Co (KO) relatively stable, with a marginal increase of 0.08%. However, the value of these shares decreased from $15,499,000 in Q1 2023 to $14,934,000 in Q2 2023.
APPLE INC (AAPL)
Castle Rock Wealth Management, LLC reduced its shares of Apple Inc (AAPL) by 8.7% in Q2 2023. Despite the decrease in shares, the value of these holdings increased from $10,402,000 in Q1 2023 to $11,306,000 in Q2 2023.
ISHARES TR (SGOV)
Castle Rock Wealth Management, LLC significantly increased its shares of iShares TR (SGOV) by 382.4% in Q2 2023. This substantial increase indicates a strong belief in the growth potential of this investment. The value of these holdings also rose from $1,922,000 in Q1 2023 to $9,276,000 in Q2 2023.
VANGUARD SCOTTSDALE FDS (VGSH)
Castle Rock Wealth Management, LLC experienced a notable decrease in its holdings of Vanguard Scottsdale FDS (VGSH) by 41.9% in Q2 2023. The value of these shares dropped from $15,086,000 in Q1 2023 to $8,758,000 in Q2 2023.
MICROSOFT CORP (MSFT)
Castle Rock Wealth Management, LLC slightly increased its shares of Microsoft Corp (MSFT) by 10.9% in Q2 2023, indicating a positive sentiment towards the company. The value of these shares also rose from $6,772,000 in Q1 2023 to $7,512,000 in Q2 2023.
ISHARES TR (TFLO)
Castle Rock Wealth Management, LLC did not hold any shares of iShares TR (TFLO) in Q1 2023. However, they acquired 146,414 shares of this stock in Q2 2023, with a value of $7,388,000.
SPDR S&P 500 ETF TR (SPY)
In Q2 2023, Castle Rock Wealth Management, LLC kept its holdings of SPDR S&P 500 ETF TR (SPY) relatively stable, with a slight increase of 0.76%. The value of these shares increased from $5,389,000 in Q1 2023 to $5,819,000 in Q2 2023.
This is just a glimpse into the changes in Castle Rock Wealth Management, LLC's holdings during Q1 and Q2 of 2023. The 13F filings provide valuable information about the investment decisions made by various funds. It remains to be seen how these changes will impact the overall performance of Castle Rock Wealth Management, LLC's portfolio.
Other Posts
- Lyons Wealth Management Q3 2019 vs. Q4 2019: Trends, Changes, and Performance
- Sigma Investment Counsellors Inc Q3 2022 vs. Q4 2022 13F Holdings Comparison: Analyzing the Changes in Holdings of the Firm
- Geneva Capital Management LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Hendershot Investments Inc. Q4 2022 vs. Q1 2023: A Comprehensive Review of Changes in 13F Holdings
- Affinity Investment Advisors Reveals Q3 2022 vs. Q4 2022 13F Holdings: Which Stocks are on the Rise?
- Allure Beauty Concepts: Accelerating Growth with Investment in Kleen Concepts
- Tobías Martinez, Former Cellnex CEO, Joins Antin Infrastructure Partners as Senior Advisor
- Oberson’s and Dyna-Mist Join Trinity Hunt Partners’ Commercial Landscaping Platform, Visterra
- Chemours: Completing the Sale of Glycolic Acid Business to PureTech Scientific
- Perkins Capital Management Inc Q1 2023 vs. Q2 2023 13F Holdings Comparison